Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-01-05 @ 11:53 PM
Study NCT ID:
NCT04588194
Status:
UNKNOWN
Last Update Posted:
2020-10-19
First Post:
2020-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
Sponsor:
David Gomez Almaguer
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Hospital Universitario
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None